Figures

Lab/R&D Fundamentals Weaken Despite Improving Demand Drivers

U.S. Life Sciences | Q2 2026

July 31, 2026 2 Minute Read

Looking for a PDF of this content?

Executive Summary

  • Lab/R&D net absorption was negative for the second consecutive quarter at -1.2 million sq. ft., driven by occupancy declines in West Coast markets.
  • The lab/R&D vacancy rate reached a new high of 23.8%.
  • Average triple-net asking rent fell by 8.1% year-over-year to $65.95 per sq. ft., the sixth consecutive quarterly drop.
  • Biotech R&D employment growth rose at its fastest pace since mid-2023, while annual venture capital funding reached its highest level since Q3 2022
  • Tenant requirements for lab/R&D space increased for the first time in a year by nearly 500,000 sq. ft.